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ABSTRACT 
The  location  of  myelin  encephalitogenic  or  basic  protein  (BP)  in  peripheral 
nervous  system  (PNS)  and  central  nervous  system  (CNS)  was  investigated  by 
immunofluorescence and  horseradish  peroxidase  (HRP)  immunocytochemistry. 
BP or cross-reacting material could be clearly localized to myelin by immunoflu- 
orescence  and  light  microscope  HRP  immunocytochemistry.  Fine  structural 
studies proved to be much more difficult, especially in the CNS, due to problems 
in  tissue  fixation  and  penetration  of reagents.  Sequential  fixation  in  aldehyde 
followed by ethanol or methanol provided the best conditions for ultrastructural 
indirect  immunocytochemical  studies.  In  PNS  tissue,  anti-BP  was  localized 
exclusively to the intraperiod line of myelin. Because of limitations in technique, 
the localization of BP in CNS myelin could not be unequivocally determined.  In 
both PNS and CNS tissue, no anti-BP binding to nonmyelin cellular or membra- 
nous elements was detected. 
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The chemical composition  of central  nervous sys- 
tem (CNS) and peripheral  nervous  system (PNS) 
myelin has been  extensively investigated,  but the 
topographical  arrangement  of  proteins  and  the 
stabilizing forces in the ordered structure  of mye- 
lin lamellae  are unknown. Myelin differs substan- 
tially from other membranes  in  its high lipid-to- 
protein  ratio (28, 42, 18). The major proteins  of 
CNS myelin are  proteolipid,  encephalitogenic  or 
basic protein  (BP),  and  Wolfgram  protein  which 
comprise  approx.  50%,  30%, and 20%, respec- 
tively, of myelin proteins  (24).  Much lower con- 
centrations  of other proteins,  such as the  DM-20 
(3) or intermediate  band protein (32,  12) and a 
glycoprotein  (46),  may also  be  present  in  CNS 
myelin. 
The most completely  characterized  of the CNS 
myelin proteins  is BP which induces experimental 
allergic encephalomyelitis  (28,  35,  21).  In  most 
mammals  BP has  a  monomer mol wt of 18,500 
and  contains  169  amino  acids.  The  rat,  mouse, 
and  related  species  have  in  addition  a  second 
smaller  BP  with a  molecular  weight  of  14,300 
(38).  The  amino  acid  sequence  (19)  has  been 
established  for BP from human (13)  and bovine 
(26)  brain  and for the small BP of the  rat  (23). 
The protein  has  been  postulated  to be  of major 
importance  in myelin structure  because  its group- 
ing  of  apolar  and  charged  amino  acids  would 
provide  for  both  hydrophobic  and  hydrophilic 
interaction  (27).  BP  was  initially isolated  from 
the  CNS,  but  more recent studies  have  demon- 
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nated PI, very similar to, if not identical with, BP 
(31,  9,  49).  The  amount  of  P1  in  PNS  myelin 
varies  considerably  among  species  (28,  31),  at- 
taining a  maximum of approx. 50%, in the guinea 
pig,  of the  concentration  of BP  in  CNS  myelin. 
The two other major proteins of PNS  myelin are 
a  glycoprotein  (25,  54),  Po  (31,  10),  of  30,000 
daltons and a  smaller protein,  P2,  with a  mol wt 
of 12,000  (11,  10,  36).  BP and its PNS counter- 
part  are restricted to neural tissue and appear to 
be  the  only  major  myelin  protein  common  to 
both CNS and PNS. The present study was under- 
taken  to  localize  this protein(s)  in  the  PNS  and 
CNS. 
MATERIALS  AND  METHODS 
Preparation of Basic Proteins 
Monkey and guinea pig brains were purchased (Pel- 
Freeze Bio-Animals, Inc., Rogers, Ark.). Bovine brain 
was obtained within 2 h of death from a local slaughter- 
house.  BP  from  guinea  pig,  monkey,  and  cow  was 
isolated according to previously described methods (21, 
51,  15).  Briefly,  this consisted of  defatting the  brain 
specimens  in  chloroform-methanol  (2/1)  followed  by 
treatment with acetone, washing with H20 and extrac- 
tion  in  dilute  HCI  at  pH  3.  The  acid  extracts  were 
chromatographed  on  carboxymethylceilulose  (CM-C) 
(Whatman CM 52, H. Reeve Angel Co., Inc., Clifton, 
N.J.) in 0.05 M glycine-NaOH buffer, pH 10.5, contain- 
ing 6  M  urea.  BP,  which binds to  CM-C under these 
conditions, was eluted with a linear gradient of 0-0.2 M 
NaCI in the same buffer containing 2 M urea. The last 
fraction, termed component 1 (20), of BP eluting from 
the  column  was  desalted  on  Sephadex  G-25  coarse 
(Pharmacia  Fine  Chemicals,  Div.  of  Pharmacia,  Inc., 
Piscataway, N.J.) in 0.5%  acetic acid, lyophilized, and 
used for immunochemical tests. Purity of the BP prepa- 
rations  was  monitored by  disk  electrophoresis in  5% 
acrylamide gels at pH 2.5 in the presence of 8 M  urea 
(21). Component 1 of guinea pig and bovine BP were 
used without further purification. The monkey BP prep- 
aration was filtered through a  1.5  x  90-cm column of 
Sephadex G-100 (Pharmacia) equilibrated with 0.01 N 
HCI  to  remove  materials,  presumably  BP  breakdown 
products, which had a greater cathodal migration in the 
acid urea gels. Bovine BP used for preparation of the 
immunoadsorbent (see below) was obtained by combin- 
ing fractions 1-4 (20) eluted from the CM-C. 
Antiserum to Basic Protein 
Rabbit (R47) antiserum to monkey BP was prepared 
by immunizing with BP complexed to deoxyribonucleic 
acid (49). This antiserum has been previously character- 
ized  as  to  specificity,  tissue  reactivity,  and  antigenic 
regions of bovine BP recognized (49, 51). The extent of 
cross-reaction of R47 (anti-monkey BP) with guinea pig 
and bovine BP was assessed by the quantitative micro- 
complement fixation test (QMCT) (49, 48). 
In  order  to  demonstrate  specificity  of reactions by 
selectively  removing  anti-BP,  a  BP-immunoadsorbent 
was prepared. 1,500 mg of AH Sepharose 4B (Pharma- 
cia) were washed with 300 ml of 0.5  M NaCI and 100 
ml  of distilled  H20  and  then suspended  in  10  ml  of 
distilled H~O.  100 mg of bovine BP, fractions 1-4, were 
added and the pH was adjusted to 4.5 with 0.1 N HC1. 
With the pH  maintained at 4.5,  5  ml of distilled H20 
containing 60 mg of 1-ethyl-3 (3-dimethyl-aminopropyl)- 
carbodiimide HCI (Sigma Chemical Co., St. Louis, Mo.) 
were  added. This mixture was gently agitated at 25~ 
for  18 h, washed successively  with 200 ml of distilled 
H20,100 ml of 0.5% acetic acid, and 200 ml of borate- 
saline buffer (41), and stored in the same buffer. 
The bovine BP-AH-Sepharose was placed in a  1.5  x 
5-cm column at 25~  and washed thoroughly with the 
borate-saline buffer.  2  ml of R47  serum  were  passed 
through the column, and the effluent was monitored at 
280 nm. The initial peak of antiserum which had been 
absorbed with BP was concentrated by vacuum dialysis 
to the starting volume. 
Horseradish  Peroxidase  Conjugates 
Goat antiserum to rabbit IgG, its selective purification 
on a  column of rabbit IgG attached to  Sepharose 2B 
(Pharmacia),  formation  of  Fab,  and  the  conjugation 
through glutaraldehyde of the Fab to horseradish perox- 
idase (HRP) (type VI, Sigma) by the one-step method 
of  Avrameas  (5),  were  performed  as  previously  de- 
scribed  (49,  41).  Some  of the  studies  were  also con- 
ducted  with Fab conjugated to  HRP  by the  two-step 
method of Avrameas and Ternyck (6, 50). The immu- 
nochemical reactants which  have goat  anti-rabbit IgG 
activity and are  linked to  HRP  will  be referred to  as 
HRP-Fab. 
Immuno  fluorescence 
Human  stellate  ganglion  and  femoral  nerve  were 
obtained postmortem and quick-frozen in 2-methylbu- 
tane cooled in liquid N2.  8-/.Lm cryostat sections were 
cut,  air-dried,  and  fixed  in  95%  ethanol  or  100% 
methanol for 5 min at 25~  The sections were washed 
in 0.01 M phosphate buffer, pH 7.2, containing 0.15 M 
NaCI and processed by an indirect immunofluorescence 
technique  (52).  R47  anti-BP  was  used  in  the  first 
reaction and goat anti-rabbit IgG (49) which had been 
conjugated  with  fluorescein  (41,  14)  was  the  second 
antibody. Sections were viewed with epi-illumination. 
Immunoperoxidase Studies 
All the indirect immunoperoxidase studies for locali- 
zation of antibody to BP were performed with normal 
adult guinea pigs weighing 400-800 g. 
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Fresh frozen and fixed frozen material were studied. 
Guinea pigs were anesthetized with sodium pentobarbi- 
tal (38 mg/kg), and portions of the sciatic nerve, spinal 
cord, and basal ganglia were removed and frozen in 2- 
methyl-butane cooled in liquid N2. Fresh frozen material 
was  used  in an  effort to  arrange  fixation for optimal 
immunocytochemical  reactions.  Cryostat  sections,  10 
/an, were placed on glass slides and fixed for 3 rain in 
one  of  the  following  fixatives:  95%  ethanol,  100% 
methanol; 0.1 M phosphate-buffered formalin (5% and 
10%), glutaraldehyde (1% and 2.5%) and paraformal- 
dehyde  (1%  and  4%);  Bouin's  fixative  (8),  formol- 
calcium  solution  (8),  Clarke's  solution  (8),  Carnoy's 
solution  (8),  6%  formalin-ethanol,  8%  formalin- 
ethanol-glacial acetic acid, 2.5%  glutaraldehyde-ethanol, 
2.5%  glutaraldehyde-methanol,  2.5%  glutaraldehyde- 
ethanol-glacial acetic acid; and  1% glutaraldehyde-4% 
formalin-ethanol-glacial acetic acid. 
Fixed frozen material was obtained from anesthetized 
animals perfused through the heart with 0.1  M  phos- 
phate buffer, pH 7.2, containing 10% formalin, 2.5% 
glutaraldehyde, or  4%  paraformaldehyde.  Portions of 
the sciatic nerve, brachiai plexus, spinal cord, and basal 
ganglia were frozen in 2-methylbutane cooled in liquid 
Nz.  Cryostat  sections,  10  /zm,  were  placed  on  glass 
slides. These fixed frozen sections were refixed in 95 % 
ethanol for 3 min. 
Both the fresh frozen and fixed frozen tissues were 
then processed  at  250C  as  follows:  the  sections were 
washed in 0.01 M phosphate buffer, pH 7.2, in 0.15 M 
NaCI (PBS) for 10 min. They were then incubated for 1 
h in a  1:25-1:50 dilution of rabbit anti-BP; washed for 
15 min in PBS, and incubated for 1 h in a  1:75-1:100 
dilution  of  HRP-Fab.  After  another  15-min  wash  in 
PBS, the sections were reacted for 30 min at 4~  in a 
solution containing 5 mg 3-3'-diaminobenzidine (DAB) 
(Sigma) in 10 ml of Tris-HCl buffer, pH 7.4, with 0.1 
ml of freshly prepared 1% H20=  (41, 30). The sections 
were  washed  in  PBS  for  15  min,  posffixed  in  1% 
osmium tetroxide in 0.1 M phosphate buffer for 5 min, 
dehydrated in graded ethanol solutions and xylene and 
mounted in Permount (41). 
Electron Microscope Studies 
Guinea pigs were anesthetized and perfused through 
the heart with 0.1 M phosphate buffer, pH 7.4, contain- 
ing 10% formalin or 2.5%  glutaraldehyde. Portions of 
the  sciatic nerve,  spinal cord,  and  basal ganglia were 
removed and sectioned at 50 /zm on a Smith-Farqhuar 
tissue sectioner. The sections were then refixed in 95% 
ethanol  for  10  rain  and  washed  in  PBS  for  10  min. 
These sections were incubated in a  1:25-1:50 dilution 
of rabbit anti-BP for 8 h at 25"C and washed for 18 h at 
25~  in PBS. This was followed by an 8-h incubation in 
a  1:75-1:100  dilution of HRP-Fab  and  a  subsequent 
overnight wash  in  PBS.  The  sections were  refixed  in 
2.5%  glutaraldehyde  in  0.1  M  phosphate buffer,  pH 
7.4 for 30 min, washed in PBS for 10 min, and reacted 
with  a  solution  of  DAB  as  described  above.  After 
postfixation in 1% osmium tetroxide in 0.1 M phosphate 
buffer, pH 7.4, for 1 h, the sections were dehydrated in 
graded ethanols and propylene oxide and embedded in 
Spurr  low-viscosity  embedding  media  (Polysciences, 
Inc., Warrington, Pa.). Thin sections were viewed with 
and  without  counterstaining with  uranyl  acetate  and 
lead citrate (47) at 50 and 75 kV in a Hitachi Hu-11B 
electron microscope. 
RESULTS 
Immunochemical  Characterization of Anti- 
BP 
Since guinea pig neural  tissue was selected for 
the  immunoperoxidase  studies,  it  was necessary 
to show that  the  rabbit  (R47)  anti-BP cross-re- 
acted  well  with  guinea  pig  BP.  Proof of cross- 
reactivity seemed particularly necessary when the 
reaction  with  guinea  pig  tissue  was  limited  or 
absent, a problem ultimately related to difficulties 
in fixation (vide infra). Cross-reactivity with bo- 
vine BP was assessed because the immunoadsorb- 
ent was prepared with bovine BP. 
As demonstrated by the QMCT at dilutions of 
1:300  or  less,  R47  cross-reacted  essentially 
equally well with monkey, guinea pig, and bovine 
BP (Fig. 1). On further dilution, this cross-reactiv- 
ity  was  less,  especially  with  bovine  BP  (49); 
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FIGURE  1  Quantitative  complement  fixation  (C  Fix) 
between  anti-BP,  diluted  1:300,  and  monkey  (Q), 
guinea pig (￿9  and bovine (A) EP. 
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which much lower dilutions were used, the cross- 
reaction of anti-monkey BP with guinea  pig BP 
should have been virtually complete. 
Immunocytochemical Tissue Studies 
PERIPHERAL  NERVOUS  SYSTEM"  In  order  to 
define a method of fixation which would be appli- 
cable for  preservation  of tissue  detail for  ultra- 
structural examination, different methods of fixa- 
tion  were tried on  flesh frozen  PNS  tissue. The 
results  of these  various  methods  of  fixation  in 
relationship to tissue binding site of antibodies to 
BP  are  shown  in  Table  I.  Fixation of tissue  in 
95% ethanol, absolute methanol, or Clarke's and 
Camoy's solutions demonstrated the  reaction of 
anti-BP  with  myelin.  In  the  sciatic  nerve  and 
brachial plexus, the staining reaction was confined 
to the myelin sheath without evidence of staining 
of Schwann cell cytoplasm or nuclei (Hgs. 2 and 
3).  The  endoneurial,  perineurial  or  epineurial 
connective tissue, or blood vessel walls showed no 
localization of anti-BP. Immunofluorescence stud- 
ies of human femoral nerve (Fig. 4) and stellate 
ganglion showed similar reactions restricted to the 
myelin sheath. The thick myelin sheaths of fem- 
oral  nerve  and  the  myelin  sheaths  of  varying 
thickness  in  the  stcllate  ganglion  were  sites  of 
antibody reaction. No reaction with  the unmye- 
TABLE I 
Effects of Fixatives on B  P Localization 
BP localized to 
Fixative  myelin sheath 
Ethanol (95%)  + 
Methanol (100%)  + 
Clarke's solution (ethanol-acetic acid)  + 
Carnoy's solution  (ethanol-acetic  acid-  + 
chloroform) 
Formalin (10%)  0 
Paraformaldehyde  (1% and 4%)  0 
Formoi-calcium  0 
Bouin's fixative (picric acid, formalin,  0 
acetic acid) 
Glutaraldehyde (1% and 2.5%)  0 
Formalin (6%)-ethanol  + 
Formalin (8%)-ethanol-acetic  acid  + 
Glutaraldehyde  (2.5%)-ethanol  or  + 
methanol 
Glutaraldehyde  (2.5 % )-ethanol-acetic  + 
acid 
Glutaraldehyde (1%)-formalin  (1%)-  + 
ethanol-acetic acid 
linated  fibers  or  Schwann  cells  in  the  stellate 
ganglion was detected. 
By immunoperoxidase technique,  fresh frozen 
PNS tissue fixed in other solutions including for- 
malin,  paraformaldehyde,  glutaraldehyde,  or 
Bouin's fixative either failed to react with anti-BP 
or led to a variable staining of many morphologic 
structures. This included sporadic staining of axis 
cylinders and  interstitial tissue elements by both 
preimmune  and  postimmunization  serum  from 
R47. 
Since alcohol appeared to preserve the localiza- 
tion of the BP in fresh frozen tissue, studies were 
undertaken  to examine the effects of combining 
an  aldehyde  fixative  in  varying  concentrations 
with  ethanol,  methanol,  or  ethanol-acetic acid. 
By use of these mixtures, specific myelin sheath 
staining  with  anti-BP  could  still  be  preserved 
(Table I). However, none of these mixtures could 
be successfully used as perfusates for retention of 
fine structural detail. 
Fixative studies were then  conducted on  fresh 
frozen  sections sequentially exposed to  an  alde- 
hyde followed by an alcohol. In sequentially fixed 
sections, anti-BP reacted with the myelin sheath 
but  not  with  other  neural  tissue  elements.  This 
procedure  for  sequential  fixation  provided  the 
best  morphological preservation for light micro- 
scope  studies  and,  subsequently,  for  ultrastruc- 
tural  investigations.  In  this  procedure  the  PNS 
tissue  was removed  after cardiac perfusion with 
10% formalin, 2.5%  glutaraldehyde, or 4% par- 
aformaldehyde. The  tissue  was  frozen,  and  the 
cryostat  sections  were  refixed  in  95%  ethanol. 
Specific localization of antibodies to BP was pre- 
served as illustrated in Fig. 5. 
For ultrastructural studies of PNS,  the  sciatic 
nerve  was  removed  from  animals perfused with 
2.5%  glutaraldehyde  or  10%  formalin.  50-/~m 
sections  were  immediately  immersed  in  95% 
ethanol and processed as described above. After 
either method of fixation, the compact regions of 
the myelin sheath were well preserved. However, 
the transitional area of continuity between these 
regions  of  compact  myelin  and  the  inner  and 
outer mesaxons could not be clearly demonstrated 
because  of tissue disruption.  In control sections 
reacted with preimmune serum, anti-BP absorbed 
with  BP,  or  DAB  alone,  no  HRP-Fab deposits 
were  found.  In  control sections  (Fig.  6),  major 
dense and intraperiod lines were distinct and the 
double  membrane  structure  of  the  intraperiod 
line  was  evident.  The  periodicity of  the  major 
MENDELL AND  WHITAKER Localization  of Myelin Basic Protein  505 FIGURE 2  Fresh frozen cryostat section of guinea pig sciatic nerve fixed in 95% ethanol and processed 
by HRP immunocytoehemical technique after anti-BP. Only myelin sheaths show staining  with HRP.  ￿ 
200. 
FiGuge  3  Control section  of sciatic  nerve; processing  identical to that for Fig.  2 but reacted with R47 
preimmune serum. The myelin sheaths are unstained.  ￿  200. 
~FIGU~ 4  Fresh frozen cryostat section of human  femoral nerve fixed in  absolute methanol.  Indirect 
immunofluorescence with anti-BP shows binding restricted to myelin sheaths.  Blood vessel (v) wall and 
perineurium (p) show some autofluorescent areas,  x  360. 
FIGURE 5  Cryostat sectlon  of sciatic  nerve from guinea pig perfused with  10%  formalin, sequentially 
fixed  in 95%  ethanol and processed by HRP immunoeytochemical technique with anti-BP. The myelin 
sheaths  are better preserved than in Fig. 2. HRP deposits are restricted to myelin sheaths,  x  300. 
dense lines was  13.5-14.5  nm, and the centers of 
the major dense and  intraperiod  lines were sepa- 
rated  by  6.5-7  nm.  BP  was  localized  in  the 
intraperiod  line (Figs. 7-10)  of PNS myelin from 
animals perfused with glutaraldehyde or formalin. 
Fine  structure  details  were  generally  better  pre- 
served in glutaraldehyde-fixed tissue (Fig. 7). The 
reaction  product  appeared  to  be  deposited  on 
both  laminae  of  the  intraperiod  line  with  less 
deposition  in  the  area  between  laminae.  In  for- 
malin-fixed material  (Figs.  8-10),  more  lamellae 
were  sites  of reaction  for anti-BP.  In  Fig.  8,  the 
HRP-Fab  deposits  appear  on  alternate  lameUae 
of the  myelin  sheath.  This  interpretation  is  sub- 
stantiated in Fig. 9, not counterstained with uranyl 
acetate  or lead  citrate,  showing  anti-BP localiza- 
tion  confined  to only one  of the  myelin lamellae 
with  a  periodicity  of  13.5-14.5  nm.  This  was 
determined  to  be  the  intraperiod  line  by  careful 
comparison with controls reacted with preimmune 
serum  (Fig.  6)  where  no  reaction  product  was 
found  in  the  intraperiod  line.  Further  evidence 
that  the  intraperiod  line  was  the  site  of anti-BP 
localization was ascertained from the areas of the 
506  THE JOURNAL OF  CELL BIOLOGY ￿9 VOLUME 76, 1978 FIGURE  6  Electron micrograph of sciatic nerve myelin perfused with 10% formalin, sequentially fixed 
in 95%  ethanol and processed by HRP  immunocytochemical technique with R47  preimmune serum. 
Intraperiod line shows double membrane structure (arrow). Stained with uranyl acetate and lead citrate. 
Bar, 0.05 ~m. x  285,000. 
FIGURE  7  Sciatic nerve myelin perfused with 2.5% glutaraldehyde, sequentially fixed in 95% ethanol, ex- 
posed to anti-BP and processed by HRP immunocytochemical technique. HRP deposits are seen in the 
intraperiod line (arrow). Stained with uranyl acetate and lead citrate,  x  285,000. 
FIGURE  8  Processing of myelin sheath identical to that in Fig. 7 except that initial perfusate was 10% 
formalin. HRP deposits are  seen in the intraperiod line (arrow).  Stained with uranyl acetate and lead 
citrate, x  285,000. 
FIGURE  9  Myelin sheath processed as in Fig.  8  without counterstaining with uranyl acetate and lead 
citrate. HRP deposits are seen in the intraperiod line (arrow).  x  285,000. 
FIOURE 10  Processing  of  myelin  identical  to  that  in  Fig.  8.  Area  of  myelin  sheath  where  HRP 
deposition is contiguous with unpenetrated region. HRP deposits can be seen in alternate lamellae of the 
myelin sheath at the right. Where the deposition terminates, the intraperiod line can be dearly identified 
(arrow).  x  285,000. 
507 myelin sheath where HRP deposition was contig- 
uous  with  unpenetrated  regions.  In  these  sites, 
HRP  deposition terminated to  expose the  intra- 
period line (Fig. 10). 
Central Nervous System 
Once having established a suitable methodology 
for light and electron microscope examination of 
PNS  tissue,  similar  studies  were  attempted  on 
CNS tissue. In order to have  comparable condi- 
tions for studies of PNS and CNS and since more 
extensive  areas  of  the  PNS  were  stained  when 
formalin was the initial fixative, 10%  phosphate- 
buffered formalin was  exclusively used  for  CNS 
studies. As with PNS tissue, the formalin-perfused 
brain was removed and 10-/~m (light microscope) 
cryostat sections or 50-/~m (electron microscope) 
"tissue-chopped"  sections  were  refixed  in  95% 
ethanol. At the light microscope level, localization 
of antibodies to  BP was confined to  the  myelin 
sheaths as illustrated in Fig. 11 which shows HRP 
staining in the bundles of myelinated nerve fibers 
coursing through the caudate nucleus and corpus 
callosum. White matter of cerebellum, brainstem, 
and  spinal  cord  also showed  reaction  with  anti- 
BP.  As  previously noted  (49),  no  staining  was 
seen  in  the  cytoplasm  or  nuclei  of  CNS  cells 
(neurons, oligodendroglia, or astrocytes). Control 
sections  incubated  with  R47  preimmune  serum 
(Fig.  12)  or R47  absorbed with  BP revealed no 
reaction with myelin. 
In  ultrastructural studies of CNS,  it proved to 
be  much  more  difficult to  obtain  penetration of 
reagents  for  an  immunocytochemical  reaction. 
Despite the use of HRP-Fab conjugates to reduce 
the size of the labeled second antibody, acceptable 
penetration and reactivity for unequivocal identi- 
fication  of the  localization of BP  in  the  myelin 
sheath was not possible. 
DISCUSSION 
This  investigation has  demonstrated  that  BP  or 
an  immunologically related  protein,  presumably 
P1  (31,  10), could be detected only in the intra- 
period line of the compact region of PNS myelin. 
Numerous technical problems, especially concern- 
ing fixation, were encountered. An aldehyde fixa- 
tive  and  exposure to  ethanol  or  methanol  were 
required for satisfactory morphology, penetration 
of reagents,  and  preservation  of tissue  antigens 
for reaction with antiserum. The effect of alcohol 
on  the  reaction remains to be defined but could 
be  related  to  the  extraction  of  certain  myelin 
lipids that mask BP or to rearrangements within 
the  myelin  membrane  to  make  antigen-binding 
sites more accessible (2, 16). Alterations in myelin 
composition,  especially lipids, effected  by  alde- 
hyde and alcohol may have influenced our results, 
but this treatment was essential for immunocyto- 
chemical reactions. 
In this immunocytochemical system, no reaction 
was detected to indicate the presence of BP in the 
FIOURE 11  Cryostat  section from guinea  pig brain perfused  with  10%  formalin,  sequentially fixed in 
95%  ethanol,  reacted with  anti-BP  and  processed  by  HRP  immunocytochemical  technique.  Large 
bundles of myelinated nerve fibers stained with HRP can be seen coursing through the eaudate nucleus 
with corpus callosum at extreme left.  ￿  125. 
FmuR~ 12  Control  section of caudate nucleus processed  as in Fig.  11  except for reaction  with R47 
preimmune  serum.  Bundles of myelinated  nerve fibers can be faintly seen.  Small black dots represent 
peroxidase staining of some remaining erythrocytes,  x  125. 
s0g  THE  JOURNAL OF CELL BIOLOGY. VOLUME 76, 1978 oligodendroglia or P1  in the Schwann cell. Small 
quantities  could  have  gone  undetected  or  been 
altered by fixation so  that  they  were  no  longer 
demonstrable.  Glutaraldehyde  alters  the  immu- 
noreactivity of BP in solution (50), but its effect 
on  BP  in  the  myelin  sheath  may  not  be  so 
extensive (53). By immunofluorescence and HRP 
immunocytochemistry conducted under a  variety 
of conditions, reaction with  cellular elements in 
CNS  or  PNS  tissue  was  never  observed.  These 
findings suggest  that  the  cells of origin of CNS 
and PNS myelin do not contain BP or P1  in the 
same state in which it occurs in the myelin sheaths. 
Previous studies on isolated oligodendroglia have 
indicated that  BP  is not found in  calf oligoden- 
droglial plasma membrane  (43).  It has been  re- 
ported that BP is present in preparations of human 
oligodendroglia (34), but the possible attachment 
of BP to human oligodendroglia during the purifi- 
cation  process  (40)  limits  the  interpretation  of 
such findings. Antibodies raised against oligoden- 
droglia do not react with CNS myelin (45) or BP 
(1). The remarkable chemical differences between 
plasma and myelin membranes indicate that these 
structures are very different. Our findings in the 
PNS  would  be  consistent  with  the  speculation 
that formation of the CNS myelin sheath involves 
a  precursor phase (17, 39, 4) in which BP exists 
in a form (in the cell of origin) that cannot react 
with  anti-BP.  Unfortunately,  fixation  of  tissue 
and  reliability of penetration  by  reagents  were 
not suitable to identify with certainty the transition 
point  between  negatively staining  Schwann  cell 
and the positively staining compact PNS myelin. 
Despite our relative success with PNS myelin, 
the ultrastructural localization of BP in the CNS 
was  not  successfully delineated. The  immunocy- 
tochemical reaction in CNS was very limited and 
usually seen best only with tissue disruption. Oth- 
ers (33) have made similar observations. Cells in 
the  CNS,  whether  disrupted or not,  showed  no 
reaction. An accurate immunocytochemical local- 
ization  of BP  in  CNS  must  await  technical  im- 
provements  which  we  have  not  been  able  to 
achieve. 
Localization of BP or P1 to the intraperiod line 
of PNS myelin differs from some of the results of 
investigations of the  distribution of BP  in  CNS 
myelin. Two of these studies (33, 37) involved an 
immunocytochemical  approach;  impaired  pene- 
tration of reagents was a  major problem in both. 
Although BP was localized in paraformaldehyde- 
fixed CNS myelin to the major dense line, staining 
occurred  only  when  myelin  was  disrupted.  The 
fixative  used  or  the  specificities of the  anti-BP 
could have restricted the detection of BP.  Reac- 
tion product was also present on the oligodendrog- 
lial plasma membrane and on postsynaptic densi- 
ties  in  sections  treated  with  both  immune  and 
normal rabbit serum. 
Studies of myelin structure after partial autolysis 
(22) or treatment with enzymes (55, 7) have not 
localized BP  with  certainty and  are in  disagree- 
ment over the position of BP in the CNS myelin 
lamellar  array.  Surface  labeling  of  intact  CNS 
myelin membrane by nonpermeant probes failed 
to label BP well but did label other myelin pro- 
teins  (44,  29,  56).  Negative  results  by  these 
techniques  are  difficult  to  interpret,  but  such 
findings would be expected in a myelin membrane 
model in which BP is not openly exposed on the 
external surface  but  located in  the  major dense 
line.  Alternatively, the  lack  of  BP  labeling  by 
nonpenetrating probes, rather than indicating BP 
localization in the major dense line, could be the 
result of lack of suitable exposure  in  the  mem- 
brane of amino acid residues, e.g., tyrosine, histi- 
dine or lysine, of BP for attachment of radiolabel, 
or the masking of BP by associated myelin lipid. 
Our observation that treatment with alcohol was 
requred  for satisfactory reaction  might  also sug- 
gest that an alcohol-soluble material shielded BP. 
Whether  or  not  there  are  dissimilarities in  the 
topography of similar proteins such as BP or P1 
in the CNS or PNS myelin cannot yet be resolved. 
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